国药集团致君（深圳）坪山制药有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
64
NMPA:64
Drug Approvals
Lidocaine and Prilocaine Cream
- Product Name
- 利丙双卡因乳膏
- Approval Number
- 国药准字H20254428
- Approval Date
- Jun 3, 2025
NMPA
Sevelamer Carbonate Tablets
- Product Name
- 碳酸司维拉姆片
- Approval Number
- 国药准字H20249635
- Approval Date
- Dec 1, 2024
NMPA
Montelukast Sodium Chewable Tablets
- Product Name
- 孟鲁司特钠咀嚼片
- Approval Number
- 国药准字H20234601
- Approval Date
- Dec 5, 2023
NMPA
Montelukast Sodium Chewable Tablets
- Product Name
- 孟鲁司特钠咀嚼片
- Approval Number
- 国药准字H20223908
- Approval Date
- Nov 30, 2022
NMPA
Olmesartan Medoxomil and Amlodipine Besylate Tablets
- Product Name
- 奥美沙坦酯氨氯地平片
- Approval Number
- 国药准字H20223672
- Approval Date
- Sep 14, 2022
NMPA
Ambroxol Hydrochloride Oral Solution
- Product Name
- 盐酸氨溴索口服溶液
- Approval Number
- 国药准字H20103285
- Approval Date
- May 31, 2022
NMPA
Ambroxol Hydrochloride Oral Solution
- Product Name
- 盐酸氨溴索口服溶液
- Approval Number
- 国药准字H20073744
- Approval Date
- May 31, 2022
NMPA
Azithromycin Dispersible Tablets
- Product Name
- 阿奇霉素分散片
- Approval Number
- 国药准字H20123077
- Approval Date
- Mar 2, 2022
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- Next
Clinical Trials
No trials found
News
No news found